STORM Therapeutics Raises $56M in Series C Funding. The funds will support the advancement of STC-15, a first-in-class cancer therapy.
Amount Raised
$56 Million
Round Type
Series C
Investors
Description
STORM Therapeutics, a Cambridge-based company, raised $56M in Series C funding. Investors include M Ventures, Pfizer Ventures, and Taiho Ventures. The funding will enhance the Phase 2 study of its lead candidate, STC-15. This candidate targets RNA modifications to treat sarcoma.
Quick answer
STORM Therapeutics raised $56 Million in a Series C round, dated April 16, 2026. Investors: UTokyo Innovation Platform Co., Ltd., Fast Track Initiative, Ip Group PLC, Taiho Ventures LLC, Pfizer Ventures and M Ventures.
- How much did STORM Therapeutics raise?
- STORM Therapeutics raised $56 Million in a Series C round on April 16, 2026.
- Who invested in STORM Therapeutics?
- UTokyo Innovation Platform Co., Ltd., Fast Track Initiative, Ip Group PLC, Taiho Ventures LLC, Pfizer Ventures and M Ventures are named as investors in this round.
- What does STORM Therapeutics do?
- STORM Therapeutics is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases.
- Where is STORM Therapeutics based and how big is it?
- Fundz records about 32 employees.
- Who are the decision-makers at STORM Therapeutics?
- Fundz holds 2 contacts at STORM Therapeutics, including the Executive Director, Program Team Lead. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as STORM Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Reprogram Biosciences raised $6M (Seed) on May 29, 2026.
- Tempest Therapeutics raised $4.1M on May 29, 2026.
- Medicenna raised $253K on May 28, 2026.
- Nuclidium raised $28M (Series B) on May 28, 2026.
- Waypoint Bio raised $20M (Series A) on May 27, 2026.
- HCW Biologics raised $4M on May 21, 2026.
Who to call at STORM Therapeutics, and when
A new round usually means STORM Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day STORM Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at STORM Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at STORM Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment STORM Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
STORM Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.